Covid-19 Drug
-
{
- All
- News
- Videos
-
Ensure Adequate Stock Of Drugs Needed For Treatment Of Covid: Centre To States
The government asked states and Union Territories to ensure adequate buffer stock of the eight critical drugs used for clinical treatment of COVID-19 and advised them to review the readiness of hospitals to deal with any possible surge in cases.
-
Anti-Covid Drug Trial Shows "Robust Efficacy": AstraZeneca
Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.
-
2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
-
Reduces Hospitalisation, Says Merck Of COVID-19 Drug, Seeks India's Ok
India's Hetero Labs said on Friday it sought emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce hospitalisations and speed up recovery in mild cases.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
Need Of 3rd Anti-Covid Dose Based More Upon Conjecture Than Data: Experts
More data is needed to establish if a third anti-COVID-19 booster dose will more effectively help in fighting the surge in infections in the country as currently its requirement has been based more upon conjecture, health experts said.
-
How To Check Remdesivir Availability Anywhere In India
Remdesivir, an injectable drug used for COVID-19 treatment, has been flying off the shelves in many states alongside the rocketing coronavirus cases and amid reports of shortage of the antiviral drug.
-
Remdesivir Production To Be Ramped Up, Prices To Be Cut: Minister
The production of antiviral drug Remdesivir will be ramped up and its prices will be reduced, the government said today after reports of shortage from various parts of the country.
-
Researchers Identify Drug That Can Be Repurposed To Treat COVID-19
Researchers at the Indian Institute of Science Education and Research (IISER) Bhopal and the University of Nebraska Medical Centre (UNMC) in the US have identified a drug that can be repurposed to treat COVID-19.
-
Russian President Vladimir Putin Opens COVID Drug Plant Amid Record Cases
Russian President Vladimir Putin on Thursday inaugurated a pharmaceutical plant in Siberia that will manufacture drugs to treat COVID-19 as the country reported record high numbers of new coronavirus infections and deaths.
-
Aspirin To Be Tested As Potential COVID-19 Drug In UK Study
Painkiller aspirin will be evaluated as a possible treatment for COVID-19 in one of Britain's biggest trials, which will assess whether it might reduce the risk of blood clots in people with the disease.
-
India And South Africa Ask WTO To Waive Rules For COVID-19 Drugs
India and South Africa want the World Trade Organization (WTO) to waive intellectual property rules to make it easier for developing countries to produce or import COVID-19 drugs, a letter to the WTO shows.
-
Russia Approves 1st COVID-19 Prescription Drug For Sale In Pharmacies
Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week, the company said on Friday.
-
Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time
Gilead Sciences Inc has filed an application with the U.S. Food and Drug Administration seeking full approval for remdesivir, its experimental COVID-19 drug currently used under emergency authorization, the drugmaker said on Monday.
-
Ensure Adequate Stock Of Drugs Needed For Treatment Of Covid: Centre To States
The government asked states and Union Territories to ensure adequate buffer stock of the eight critical drugs used for clinical treatment of COVID-19 and advised them to review the readiness of hospitals to deal with any possible surge in cases.
-
Anti-Covid Drug Trial Shows "Robust Efficacy": AstraZeneca
Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.
-
2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
-
Reduces Hospitalisation, Says Merck Of COVID-19 Drug, Seeks India's Ok
India's Hetero Labs said on Friday it sought emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce hospitalisations and speed up recovery in mild cases.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
Need Of 3rd Anti-Covid Dose Based More Upon Conjecture Than Data: Experts
More data is needed to establish if a third anti-COVID-19 booster dose will more effectively help in fighting the surge in infections in the country as currently its requirement has been based more upon conjecture, health experts said.
-
How To Check Remdesivir Availability Anywhere In India
Remdesivir, an injectable drug used for COVID-19 treatment, has been flying off the shelves in many states alongside the rocketing coronavirus cases and amid reports of shortage of the antiviral drug.
-
Remdesivir Production To Be Ramped Up, Prices To Be Cut: Minister
The production of antiviral drug Remdesivir will be ramped up and its prices will be reduced, the government said today after reports of shortage from various parts of the country.
-
Researchers Identify Drug That Can Be Repurposed To Treat COVID-19
Researchers at the Indian Institute of Science Education and Research (IISER) Bhopal and the University of Nebraska Medical Centre (UNMC) in the US have identified a drug that can be repurposed to treat COVID-19.
-
Russian President Vladimir Putin Opens COVID Drug Plant Amid Record Cases
Russian President Vladimir Putin on Thursday inaugurated a pharmaceutical plant in Siberia that will manufacture drugs to treat COVID-19 as the country reported record high numbers of new coronavirus infections and deaths.
-
Aspirin To Be Tested As Potential COVID-19 Drug In UK Study
Painkiller aspirin will be evaluated as a possible treatment for COVID-19 in one of Britain's biggest trials, which will assess whether it might reduce the risk of blood clots in people with the disease.
-
India And South Africa Ask WTO To Waive Rules For COVID-19 Drugs
India and South Africa want the World Trade Organization (WTO) to waive intellectual property rules to make it easier for developing countries to produce or import COVID-19 drugs, a letter to the WTO shows.
-
Russia Approves 1st COVID-19 Prescription Drug For Sale In Pharmacies
Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week, the company said on Friday.
-
Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time
Gilead Sciences Inc has filed an application with the U.S. Food and Drug Administration seeking full approval for remdesivir, its experimental COVID-19 drug currently used under emergency authorization, the drugmaker said on Monday.
